Beone Medicines Ltd Stock Performance
as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
$312.87$319.77
2.34%
Downside
-0.19%
Upside
52 Week's Low
52 Week's High
$172.67$355.346.10%
Downside
10.90%
Upside
Beone Medicines Ltd share price movements today
- Previous Close
- $332.36
- Open
- $315.53
- Volume
- 258.7K
- Day's Low - High
- $312.87 - $319.77
- 52 Week Low - High
- $172.67 - $355.3
Beone Medicines Ltd Historical Returns
- 1 Month Return
- -8.86 %
- 3 Month Return
- + 11.03 %
- 1 Year Return
- 0 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Beone Medicines Ltd Stock Fundamentals & Key Indicators
Check Beone Medicines Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$36.6B
EPS (TTM)
3.6884
Dividend Yield
0.00%
PE Ratio (TTM)
627.09
Industry PE ratio
0PEG Ratio
0Return On Equity TTM
-4.98%
Beone Medicines Ltd Stock Valuation
Track how Beone Medicines Ltd P/E has moved over time to understand its valuation trends.
Beone Medicines Ltd in the last 5 years
Lowest (-141.76x)
June 30, 2025
Industry (0.00x)
November 8, 2025
Today (627.09x)
November 8, 2025
Highest (-62.85x)
March 31, 2025
Today’s Price to Earnings Ratio: 627.09x
Beone Medicines Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Beone Medicines Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $36.6B | NA | 627.09 | -3.89% | |
| BUY | $40.5B | 482.44% | -16.34 | -264.83% | |
| BUY | $58.2B | 238.64% | 1420.94 | 1.36% | |
| BUY | $105.6B | 85.89% | 29.33 | 31.35% | |
| BUY | $68.0B | 13.75% | 15.51 | 32.13% |
Beone Medicines Ltd Stock’s Investor Sentiment and Interest
Search interest for Beone Medicines Ltd Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Beone Medicines Ltd Quarterly Profit & Loss
All numbers in Millions USD
Beone Medicines Ltd Annual Profit & Loss
All numbers in Millions USD
Beone Medicines Ltd Quarterly Cash Flow
All numbers in Millions USD
Beone Medicines Ltd Annual Cash Flow
All numbers in Millions USD
Insights on Beone Medicines Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Beone Medicines Ltd has shown positive revenue growth over the last two quarters. The company's revenue increased from $1.11 billion to $1.31 billion, reflecting an average increase of 15.1% per quarter.
- POSITIVE IMPACT
Profit Spike
Beone Medicines Ltd has shown a strong improvement in its net profit over the last three quarters. The net profit increased from -151.88 million dollars to 94.32 million dollars, marking a significant turnaround. On average, the company has experienced a remarkable increase of about 6078.9% in net profit each quarter.
- POSITIVE IMPACT
Price Rise
In the last 7 days, ONC stock has moved up by 7.0%
NO EFFECTAgainst Peers
In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 90.7%
- NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 897.2% return, outperforming this stock by 821.5%
About Beone Medicines Ltd
| Organisation | Beone Medicines Ltd |
| Headquarters | Aeschengraben 27, Basel, Switzerland, 4051 |
| CEO | Mr. John V. Oyler |
| E-voting on shares | Click here to vote |
Key Management of Beone Medicines Ltd
Name | Title |
|---|---|
Mr. John V. Oyler | Co-Founder, Executive Chairman & CEO |
Dr. Xiaobin Wu Ph.D. | President, COO & GM of China |
Mr. Wang Lai Ph.D. | Global Head of Research & Development |
Mr. Marcello Damiani | Chief Technology Officer |
Dr. Xiaodong Wang Ph.D. | Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder |
Mr. Aaron Rosenberg | Chief Financial Officer |
Mr. Chan Lee | General Counsel & Senior VP |
Mr. Titus B. Ball | VP & Chief Accounting Officer |
Ms. Liza Heapes | Head of Investor Relations |
Ms. Eleanor Duff Ph.D. | Senior VP & Head of Corporate Communications |
FAQs
What is Beone Medicines Ltd share price today?
Beone Medicines Ltd share price today is $320.37 as on at the close of the market. Beone Medicines Ltd share today touched a day high of $319.77 and a low of $312.87.
What is the 52 week high and 52 week low for Beone Medicines Ltd share?
Beone Medicines Ltd share touched a 52 week high of $355.3 on and a 52 week low of $172.67 on . Beone Medicines Ltd stock price today i.e. is closed at $320.37,which is 9.83% down from its 52 week high and 85.54% up from its 52 week low.
What is Beone Medicines Ltd's market capitalisation today?
Beone Medicines Ltd market capitalisation is $0.04T as on .
How to invest in Beone Medicines Ltd Stock (ONC) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Beone Medicines Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Beone Medicines Ltd Shares that will get you 0.0047 shares as per Beone Medicines Ltd share price of $320.37 per share as on November 8, 2025 at 2:29 am IST.
What is the minimum amount required to buy Beone Medicines Ltd Stock (ONC) from India?
Indian investors can start investing in Beone Medicines Ltd (ONC) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Beone Medicines Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Beone Medicines Ltd share’s latest price of $320.37 as on November 8, 2025 at 2:29 am IST, you will get 0.0312 shares of Beone Medicines Ltd. Learn more about
fractional shares .